Anesthesia; Adverse Effect

4

Review clinical trials related to Anesthesia; Adverse Effect. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)

The purpose of this study is to evaluate the hemodynamics and adverse event profile in comparison between two treatment arms, one using an admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7), and one using an admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2), for anesthesia during endoscopic procedures at the Clements University Hospital (CUH) endoscopy lab (Endo).

Participants needed: 200
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: University of Texas Southwestern Medical CenterUpdated: Jan 20, 2026Locations: 1
Eligibility criteria

Adult patients (age ≥18 years old) [+3]

Known allergies or adverse reactions to study drugs or study drug components or... [+5]

Status: Recruiting

Language During Inhalational Induction

The aim of this study is to compare the impact of common (standard of care) language vs positive language used by clinicians during inhalational induction of anesthesia on anxiety and negative behaviors in children. This is a prospective randomized parallel group trial. Patients will be randomized 1:1 to the common/standard language group or the positive language group.

Participants needed: 128
Trial details
Age: 5-10Biological sex: AllType: InterventionalSponsor: Boston Children's HospitalUpdated: Jan 9, 2026Locations: 1
Eligibility criteria

ASA 1 and 2 (Healthy Patients) [+3]

Non-English speaking [+4]

Status: Recruiting

Apnoeic Oxygenation During Pediatric Tracheal Intubation

The goal of this randomized, controlled, single-blinded clinical trial is to evaluate the effectiveness of apnoeic Oxygenation in pediatric anesthesia. The main question it aims to answer are: primary outcome measure: The primary outcome will be the lowest SpO₂ value recorded during the apnoeic period. secondary outcome measure: * Differences in intubation first-pass-success (key secondary objective) * Temporal differences to achieve successful intubation * Differences in time to oxygen desaturation * Differences in heart rate and mean arterial blood pressure decrease * Differences in the incidence of anesthesia-related adverse events The study participants are randomized two age dependents groups. Either in the control group without the use of apnoeic oxygenation or in the intervention group with the use of apnoeic oxygenation. The study population will be divided into two independent cohorts, each consisting of 100 patients. The first cohort, designated as "infants" will include all patients aged up to 24 months, while the second cohort, termed "children" will comprise patients aged older than 24 months and up to six years. Within each cohort, patients will be randomized into an intervention group and a control group, with 50 patients assigned to each. This randomization will ensure that, for both the Infant and Children Groups, half of the participants (n=50) will receive the intervention, while the other half (n=50) will serve as controls. Statistical analysis of primary and secondary endpoints will be conducted independently for each cohort. This stratified approach will allow for targeted evaluation of age-specific effects of the intervention, as well as comparison between intervention and control outcomes within each age-defined cohort.

Participants needed: 200
Trial details
Age: 0-6Biological sex: AllType: InterventionalSponsor: University Hospital HeidelbergUpdated: Mar 3, 2025Locations: 1
Eligibility criteria

children 0-6 years [+2]

refusal to participate in the study by the patients or their legal guardians [+11]

Status: Not yet recruiting

Registry of Anesthesia and Perioperative Medicine

To assess mortality and morbidity associated to anesthesia interventions

Participants needed: 10,000
Trial details
Biological sex: AllType: ObservationalSponsor: Clinica Alemana de SantiagoUpdated: May 22, 2023Locations: 1Duration: 1 Year
Eligibility criteria

All individuals [+1]

The subjects who had insufficient data in their files